FolioLanternBeta
EXELExelixis, Inc.

Stelios Papadopoulos

Director at Exelixis, Inc., as of May 29, 2026Sold $4.4M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
100K
shares sold, past 12 months
1
days with sales
$4.4M
largest single day, Nov 12, 2025
2
companies filed for

Share of stake sold and shares held at Exelixis, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $4.4M no plan disclosed$4.4MNovDecJanFebMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Exelixis, Inc. (EXEL)DirectorApr 12, 2004May 29, 2026
Biogen (BIIB)Former DirectorJul 9, 2008Jun 17, 2022

Also a director at

Biogen (BIIB) (no filing in the last 18 months)

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.